Oct 25 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT
* ACELRX PHARMACEUTICALS INC - TO EFFECT A REVERSE STOCK
SPLIT OF
ITS COMMON STOCK AT A RATIO OF 1-FOR-20
* ACELRX PHARMACEUTICALS INC - REVERSE STOCK SPLIT WILL
BECOME
EFFECTIVE AT 5:01 P.M. ET ON TUESDAY, OCTOBER 25, 2022
* ACELRX PHARMACEUTICALS INC - REVERSE STOCK SPLIT TO ENABLE
CO TO
REGAIN COMPLIANCE WITH $1.00 MINIMUM BID PRICE REQUIRED FOR
LISTING ON NASDAQ
Source text for Eikon: ID:nPn7CPLqla
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))